UBS Group’s New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF LRND Stock Holding History

UBS Group's LRND Position: Q2 2026 in Review

UBS Group opened a new position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) in Q2 2026: 319 shares worth $14.1K. The stake represents ﹤0.01% of the portfolio and ranks #8366 among its holdings. This is a return to the name: UBS Group previously reported a position in LRND as recently as Q2 2025.

UBS Group first reported a position in LRND in Q4 2023 and has held it in 5 quarters since. 6 funds tracked by Wall St. Rank hold LRND as of Q2 2026.

• UBS Group held 319 shares of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF worth $14.1K as of Q2 2026.
• New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF was a new UBS Group position in Q2 2026.
• New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8366 holding.
• UBS Group first reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in Q4 2023 and has held it in 5 quarters since.
• 6 funds tracked by Wall St. Rank held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.